Aethlon Medical, Inc. (AEMD)

NASDAQ: AEMD · IEX Real-Time Price · USD
1.710
-0.020 (-1.16%)
Mar 28, 2024, 10:29 AM EDT - Market open

Company Description

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States.

It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system.

The company was founded in 1999 and is based in San Diego, California.

Aethlon Medical, Inc.
Aethlon Medical logo
Country United States
Industry Medical Devices
Sector Healthcare
Employees 15
CEO James B. Frakes M.B.A.

Contact Details

Address:
11555 Sorrento Valley Road, Suite 203
San Diego, California 92121
United States
Phone 858-459-7800
Website aethlonmedical.com

Stock Details

Ticker Symbol AEMD
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0000882291
CUSIP Number 00808Y307
ISIN Number US00808Y4061
Employer ID 13-3632859
SIC Code 3841

Key Executives

Name Position
Guy F. Cipriani BS (Eng.), MBA Chief Operating Officer
Dr. Steven P. LaRosa M.D. Chief Medical Officer
James B. Frakes M.B.A. Interim Chief Executive Officer, Chief Financial Officer, Secretary and Director
Dr. Lee D. Arnold Ph.D. Chief Scientific Officer

Latest SEC Filings

Date Type Title
Mar 22, 2024 S-1 General form for registration of securities under the Securities Act of 1933
Feb 14, 2024 10-Q Quarterly Report
Feb 14, 2024 8-K Current Report
Dec 22, 2023 8-K/A [Amend] Current report
Nov 27, 2023 8-K Current Report
Nov 14, 2023 10-Q Quarterly Report
Nov 14, 2023 8-K Current Report
Nov 13, 2023 8-K Current Report
Oct 4, 2023 8-K Current Report
Sep 18, 2023 8-K Current Report